Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (359)
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
1,891
Price
$30.26
Total Value
$57.23K
Shares Held After
80,725
% of Holdings
2.3%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
7,270
Price
$29.58
Total Value
$215.04K
Shares Held After
82,616
% of Holdings
8.1%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
8,149
Price
$28.84
Total Value
$235.03K
Shares Held After
89,886
% of Holdings
8.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,690
Price
$30.15
Total Value
$50.96K
Shares Held After
30,606
% of Holdings
5.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,983
Price
$30.15
Total Value
$59.79K
Shares Held After
36,013
% of Holdings
5.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
6,480
Price
$30.15
Total Value
$195.38K
Shares Held After
21,479
% of Holdings
23.2%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,293
Price
$119.41
Total Value
$273.81K
Shares Held After
61,441
% of Holdings
3.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
326
Price
$121.69
Total Value
$39.67K
Shares Held After
63,734
% of Holdings
0.5%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
85
Price
$122.19
Total Value
$10.39K
Shares Held After
64,060
% of Holdings
0.1%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
1,642
Price
$119.38
Total Value
$196.02K
Shares Held After
64,145
% of Holdings
2.5%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
1,643
Price
$119.51
Total Value
$196.35K
Shares Held After
65,787
% of Holdings
2.4%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,864
Price
$119.40
Total Value
$341.96K
Shares Held After
67,430
% of Holdings
4.1%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
4,695
Price
$119.39
Total Value
$560.54K
Shares Held After
70,294
% of Holdings
6.3%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
6,171
Price
$119.43
Total Value
$737.00K
Shares Held After
74,989
% of Holdings
7.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,187
Price
$119.47
Total Value
$261.28K
Shares Held After
81,160
% of Holdings
2.6%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
5,332
Price
$119.42
Total Value
$636.75K
Shares Held After
83,347
% of Holdings
6.0%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
14,661
Price
$119.46
Total Value
$1.75M
Shares Held After
88,679
% of Holdings
14.2%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
15,888
Price
$119.70
Total Value
$1.90M
Shares Held After
215,444
% of Holdings
6.9%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
48,711
Price
$8.15
Total Value
$396.99K
Shares Held After
6,584,603
% of Holdings
0.7%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Umberger Traci S — Director
Shares
8,752
Price
$22.60
Total Value
$197.84K
Shares Held After
206,995
% of Holdings
4.1%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
8,948
Price
$22.60
Total Value
$202.26K
Shares Held After
540,132
% of Holdings
1.6%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Mahboob Vaseem — Chief Financial Officer
Shares
8,817
Price
$22.61
Total Value
$199.34K
Shares Held After
99,282
% of Holdings
8.2%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Ford Alfred J Jr — Chief Commercial Officer
Shares
8,681
Price
$22.61
Total Value
$196.28K
Shares Held After
118,854
% of Holdings
6.8%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Moran Timothy P. — Chief Business Officer
Shares
8,759
Price
$22.61
Total Value
$198.00K
Shares Held After
68,725
% of Holdings
11.3%
Butterfly Network, Inc. (BFLY)
ROBBINS LARRY — Director
Shares
1,720,129
Price
$7.39
Total Value
$12.72M
Shares Held After
12,614,926
% of Holdings
12.0%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,003
Price
$4.80
Total Value
$38.41K
Shares Held After
722,419
% of Holdings
1.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$4.98
Total Value
$124.54K
Shares Held After
714,416
% of Holdings
3.5%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,300
Price
$4.98
Total Value
$16.42K
Shares Held After
689,416
% of Holdings
0.5%
SHOULDER INNOVATIONS, INC. (SI)
Gilde Healthcare Holding B.V. — 10% Owner
Shares
20,034
Price
$22.73
Total Value
$455.37K
Shares Held After
2,332,203
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
GLAUKOS Corp (GKOS)
WEN LEANA — Director
Shares
525
Price
$167.63
Total Value
$88.01K
Shares Held After
21,092
% of Holdings
2.4%
BOSTON SCIENTIFIC CORP (BSX)
LUDWIG EDWARD J — Director
Shares
5,000
Price
$45.48
Total Value
$227.40K
Shares Held After
30,359
% of Holdings
16.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
238
Price
$522.88
Total Value
$124.44K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
282
Price
$521.52
Total Value
$147.07K
Shares Held After
324,681
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,517
Price
$520.80
Total Value
$790.06K
Shares Held After
324,963
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,627
Price
$520.12
Total Value
$1.37M
Shares Held After
326,480
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,266
Price
$519.06
Total Value
$657.12K
Shares Held After
329,107
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$518.00
Total Value
$629.37K
Shares Held After
330,373
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,133
Price
$516.94
Total Value
$585.70K
Shares Held After
331,588
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
857
Price
$515.84
Total Value
$442.07K
Shares Held After
332,721
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$514.82
Total Value
$187.91K
Shares Held After
333,578
% of Holdings
0.1%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
200,000
Price
$1.77
Total Value
$353.96K
Shares Held After
500,000
% of Holdings
40.0%
CHEMED CORP (CHE)
GRACE PATRICK P — Director
Shares
190
Price
$532.00
Total Value
$101.08K
Shares Held After
3,533
% of Holdings
5.1%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
6,400
Price
$0.42
Total Value
$2.69K
Shares Held After
2,863,773
% of Holdings
0.2%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.47
Total Value
$17.35K
Shares Held After
657,000
% of Holdings
0.8%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
28
Price
$351.00
Total Value
$9.83K
Shares Held After
1,266
% of Holdings
2.2%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
24,944
Price
$9.93
Total Value
$247.69K
Shares Held After
17,329,570
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
Hayden Michael R — Director
Shares
5,000
Price
$51.60
Total Value
$258.00K
Shares Held After
24,000
% of Holdings
20.8%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
100,000
Price
$6.06
Total Value
$606.00K
Shares Held After
254,535
% of Holdings
28.2%
Showing 51–100 of 359 transactions (page 2 of 8)